Colgate-Palmolive Company $CL Stake Reduced by Danske Bank A S

Danske Bank A S lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 14.8% during the third quarter, Holdings Channel.com reports. The institutional investor owned 598,305 shares of the company’s stock after selling 104,079 shares during the quarter. Danske Bank A S’s holdings in Colgate-Palmolive were worth $51,047,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of CL. Virginia Estate & Retirement Planning Advisors Inc. lifted its position in shares of Colgate-Palmolive by 1,409.1% in the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock valued at $28,000 after buying an additional 310 shares during the last quarter. Parvin Asset Management LLC bought a new position in shares of Colgate-Palmolive during the 2nd quarter worth approximately $32,000. Park Place Capital Corp boosted its stake in shares of Colgate-Palmolive by 55.5% during the 2nd quarter. Park Place Capital Corp now owns 356 shares of the company’s stock worth $33,000 after acquiring an additional 127 shares during the period. Cherry Tree Wealth Management LLC increased its holdings in shares of Colgate-Palmolive by 7,840.0% during the 2nd quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company’s stock worth $36,000 after acquiring an additional 392 shares during the last quarter. Finally, Montgomery Financial Services LLC acquired a new position in shares of Colgate-Palmolive during the 2nd quarter worth approximately $36,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $99.62 on Monday. The company has a debt-to-equity ratio of 11.23, a current ratio of 0.96 and a quick ratio of 0.63. The stock’s fifty day moving average price is $90.94 and its two-hundred day moving average price is $90.29. Colgate-Palmolive Company has a one year low of $75.96 and a one year high of $101.18. The firm has a market cap of $79.19 billion, a price-to-earnings ratio of 39.07, a P/E/G ratio of 4.51 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its quarterly earnings data on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The firm had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.34 billion. During the same quarter last year, the business earned $0.91 EPS. The company’s quarterly revenue was up 4.6% compared to the same quarter last year. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.92 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Tuesday, October 20th were paid a $0.53 dividend. The ex-dividend date was Tuesday, October 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.1%. Colgate-Palmolive’s dividend payout ratio is 83.14%.

Insider Buying and Selling at Colgate-Palmolive

In related news, CEO Noel Wallace sold 20,000 shares of the firm’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $100.26, for a total transaction of $2,005,200.00. Following the transaction, the chief executive officer directly owned 359,700 shares of the company’s stock, valued at approximately $36,063,522. This trade represents a 5.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Gregory Malcolm sold 4,100 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $97.97, for a total transaction of $401,677.00. Following the completion of the sale, the executive vice president owned 10,061 shares of the company’s stock, valued at $985,676.17. This trade represents a 28.95% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 77,414 shares of company stock valued at $7,613,786. 0.43% of the stock is currently owned by insiders.

Key Stories Impacting Colgate-Palmolive

These are some of the CL stories that stood out recently:

  • Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $3.91 from $3.85 and made smaller increases to FY2027 ($4.06) and FY2028 ($4.38) forecasts. These revisions offer a modestly constructive earnings signal, though they are one analyst’s estimates. Zacks Research earnings estimate revisions
  • Neutral Sentiment: The estimate changes were mixed: Zacks raised some quarterly forecasts but lowered others, including Q1 2027 and Q1–Q2 2028. That tempers the positive full-year revisions and does not indicate a broad upgrade to near-term expectations. Zacks Research quarterly earnings estimate revisions
  • Negative Sentiment: A Colgate-Palmolive executive vice president sold $401,677 worth of company stock. Insider sales can weigh on sentiment, although a single transaction does not necessarily signal a change in the company’s outlook. Insider Selling: Colgate-Palmolive EVP Sells $401,677.00 in Stock

Wall Street Analyst Weigh In

CL has been the topic of a number of research analyst reports. Evercore increased their price target on Colgate-Palmolive from $100.00 to $101.00 and gave the company an “outperform” rating in a research note on Thursday, October 8th. TD Cowen lifted their price objective on shares of Colgate-Palmolive from $90.00 to $97.00 and gave the stock a “hold” rating in a research report on Monday, November 2nd. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Thursday, August 13th. Weiss Ratings downgraded shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 2nd. Finally, Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $90.00 to $95.00 and gave the company an “equal weight” rating in a research report on Monday, November 2nd. Thirteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $101.22.

Get Our Latest Report on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.